Intensity Therapeutics, Inc. (INTS) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts INTS Hot Sheet
Join SI Premium – FREE
Intensity Therapeutics, Inc. (NASDAQ: INTS) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06).
For earnings history and earnings-related data on Intensity Therapeutics, Inc. (INTS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple suing OpenAI over alleged misappropriation of trade secrets
- AutoZone promotes Grace Sharpley to SVP of Finance
- Cognizant shareholder derivative settlement gets preliminary approval
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
